Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11084798
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors
granted -
US 11083720
Indazole inhibitors of fructokinase (KHK) and methods of use in treating KHK-mediated disorders or diseases
granted -
US 11078205
Selective inhibitors of protein arginine methlytransferase 5 (PRMT5)
granted -
US 11078295
Use of semaphorin-4D inhibitory molecules with an immune modulating therapy to inhibit tumor growth and metastases
granted -
US 11072581
N-acyl-arylsulfonamide derivatives as aminoacyl-tRNA synthetase inhibitors
granted -
US 11071727
Therapeutic targeting of proteolytic cleavage of the mixed lineage leukemia gene product (MLL1) by taspase1 using kinase inhibitors
granted -
US 11072644
Inhibitory chimeric antigen receptors
granted -
US 11072600
Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer
granted -
US 11065254
Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
granted -
US 11065332
Combination therapy of immunotoxin and checkpoint inhibitor
granted -
US 11066360
Human plasma kallikrein inhibitors
granted -
US 11066420
Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof
granted -
US 11058704
Inhibitors of adenosine 5′-nucleotidase
granted -
US 11059814
Kinase inhibitors and methods for making and using
granted -
US 11058688
Imidazopiperazine inhibitors of transcription activating proteins
granted -
US 11053262
Heterocyclic amide compounds having RORyT inhibitory action
granted -
US 11052073
Sphingosine kinase 2 inhibitor for treating coronavirus infection
granted -
US 11046649
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
granted -
US 11046709
Fused 1,4-diazepines as BET bromodomain inhibitors
granted -
US 11045443
Glutaminase inhibitor therapy
granted -
US 11045461
Compositions of CXCR4 inhibitors and methods of preparation and use
granted -
US 11045448
Piperidines as covalent menin inhibitors
granted -
US 11046691
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors
granted -
US 11045453
Serine protease inhibitor for treating coronavirus infection
granted